Send Story by Email

GLP-1 weight-loss drugs may pivot to treat Alzheimer's and Parkinson's

02-03-2024 • https://newatlas.com, By Bronwyn Thompson

In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential 'superpower' in the fight against Alzheimer's and Parkinson's

Your First Name

Your Last Name

Your Email Address

Enter one or more email addresses below. Separate multiple addresses with a semicolon (;) or a new line. Maximum 10 email addresses at one time.

To Email Address(es)

Personal Note

Also Send Daily Headlines Newsletter

Freedoms Phoenix

Online Magazine

Join-Us

Newspaper

Phone Apps

Declare Your Independence with Ernest Hancock

REAL TIME SPOT PRICES

Live Broadcast

Declare Your Independence

MENU

Send Story by Email

GLP-1 weight-loss drugs may pivot to treat Alzheimer's and Parkinson's

FreedomsPhoenix.com